The European Medicines Agency has approved two new Covid-19 treatments: an antibody medication and an arthritis drug that turned out to be able to “reduce” the inflammation associated with the virus.
The first drug, Xevudy, produced by GlaxoSmithKline and Vir Biotechnology was recommended for treating the virus in adults and adolescents older than 12 who weigh at least 40 kilograms and ”who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.”
Xevudy is the third monoclonal antibody treatment approved for use in the EU after Regkirona and Ronapreve.
The second drug, Kineret, is produced by Swedish company Sobi and is an immunosuppressive medicine currently used for treatment of inflammatory conditions.
“In Covid-19 patients, the medicine is considered to reduce the inflammation associated with [the virus] and thus decrease lower airway damage, preventing development of severe respiratory failure,” the EMA said.
It is recommended for adult Covid patients with pneumonia who require supplemental oxygen and “who are at risk of developing severe respiratory failure.”
The regulator has so far approved six Covid-19 treatments, including the newest additions to the list. It is also currently considering the approval of several other treatments in its bid to lessen the impact of the fast-spreading Omicron variant. Those under consideration include Pfizer’s Paxlovid and Merck’s Lagevrio.
On Thursday, the head of the UK’s antiviral taskforce said he expected both of these drugs to be available for use there over the winter period.
According to the European Commission, the Omicron variant will become dominant in the EU by mid-January.
source: RT
Împotriva articolelor redacției noastre, persoanele nemulțumite pot formula Contestație în termen de 10 zile de la publicarea articolului, la judecătoria Orășenească nr. 1 München Bayern Deutschland, in conformitate cu Legea federală Germană. Considerăm că nu se pot formula acțiuni la instanțele din România deoarece nici o persoană care activează în trustul nostru nu poate fi extrasă de sub jurisdicția federală germană. Considerăm că redacția noastră nu răspunde în fața autorităților din România ci doar celor federale sau civile germane. deoarece legea română nu are efecte de extraneitate asupra redacției chiar dacă subiectul știrilor face obiectul unor evenimente sau persoane din România și sunt scrise în limba română. Limba română nu este izvor de extraneitate a legii.
absolvent WEB DESIGN Academia Britanică de Comunicare Iasi - absolvent COMUNICARE IN AFACERI Academia Britanica de Afaceri si Comunicare -absolvent JURNALISM EDITORIAL - London School University - 2019 inscris la echivalare diploma la Universitatea Politehnica Timisoara - absolvent studii de Drept Universitatea Europeană Drăgan, cursuri in Drept la Universitatea de Vest Timisoara, absolvent studii de proiectare, pastor coordonator in Biserica Protestanta Evanghelica,
Android Developer pe Google Play și plugin developer la Oxwall, creator de teme Wordpress și Oxwall, operator Wordpress, Drupal, Oxwall, Osclass, Moodle, tehnologii HTML și PHP
Joint military, taxation and court agreements in Bosnia-Herzegovina have been used to violate Serb rights and the 1995 peace deal, said Milorad Dodik, member of the country’s tripartite presidency from Republika Srpska. Republika Srpska, the Serb entity that makes up half of Bosnia, will start the process “by the end of this month, first week […]
At least two state attorneys general have asked donors to the Canadian truck protest to come forward, after crowdfunding site seized their cash West Virginia Attorney General Patrick Morrisey and Ohio AG Dave Yost have urged citizens who donated to the anti-vaccine mandate ‘Freedom Convoy’ in Canada to come forward, after crowdfunding site GoFundMe seized […]
A city in Austria is looking for employees who will be tasked with enforcing fines against those unwilling to get the Covid jab. The recruitment drive comes weeks ahead of a sweeping vaccine mandate in the European country. Successful candidates will be issuing penalties, processing appeals and taking measures against those who fail to shell […]
